Hemophilia care providers in the U.K. have insufficient knowledge on how to assess the risk of prolonged bleeding associated with…
Articles by Alice Melão
People with severe hemophilia A living in Europe can now receive treatment with Hemlibra (emicizumab-kxwh) to prevent bleeding episodes.
More than half of adults who either have hemophilia or are family members affected by the disease support the use…
Hemophilia patients who take intermediate‐dose preventive medication may experience more of an age-related decline in sports participation, joint status, and…
Children and adults with hemophilia A in the United States may soon be treated with N8-GP (turoctocog alfa pegol),…
SPK-8011 may be a safe treatment strategy for patients with severe or moderately severe hemophilia A, achieving an overall 97%…
Clinical data from the ongoing Phase 2/3 trial data evaluating MarzAA (marzeptacog alfa activated) in patients with Hemophilia A or…
Clinical symptoms of acquired hemophilia A in elderly patients can vary widely, a series of six case reports reveals.
Sigilon Therapeutics and the Massachusetts Institute of Technology will work together to develop programmable cell therapeutics for the treatment…
Hemophilia A patients age 12 and older who live in Canada now may receive prophylactic (preventive) treatment with…